Resolution Agonist 15-epi-Lipoxin A<sub>4</sub> Programs Early Activation of Resolving Phase in Post-Myocardial Infarction Healing.

Sci Rep · 2017 · PMC5577033 · PMID 28855632

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The 15-epi-LXA 4 treated mice showed a trend of improvement in fractional shortening, EDD (end-diastolic dimension), ESD (end-systolic dimension) and IVSd (interventricular septal end diastole) compared with MI-control mice.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.